These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 21667112

  • 1. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
    Ding DP, Ma WL, He XF, Zhang Y.
    Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
    [Abstract] [Full Text] [Related]

  • 2. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R, Zhang C, Malik A, Shen ZD, Hu J, Wu YH.
    World J Gastroenterol; 2014 Nov 28; 20(44):16765-73. PubMed ID: 25469049
    [Abstract] [Full Text] [Related]

  • 3. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
    Guo XF, Wang J, Lei XF, Zeng YP, Dong WG.
    Intern Med; 2015 Nov 28; 54(3):251-9. PubMed ID: 25748732
    [Abstract] [Full Text] [Related]

  • 4. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis].
    Wu XB, Dai LP, Wang YP, Wang KJ, Zhang JY.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar 28; 30(3):281-5. PubMed ID: 19642387
    [Abstract] [Full Text] [Related]

  • 5. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Cui J, Li D, Shen L, Zhang W, Xu X.
    Tumour Biol; 2014 Jul 28; 35(7):6335-41. PubMed ID: 24652592
    [Abstract] [Full Text] [Related]

  • 6. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
    Peng Q, Li S, Lao X, Chen Z, Li R, Qin X.
    Medicine (Baltimore); 2014 Dec 28; 93(29):e330. PubMed ID: 25546681
    [Abstract] [Full Text] [Related]

  • 7. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH, Liu C, Hu JB, Meng RR, Li L, Wang YJ.
    Asian Pac J Cancer Prev; 2013 Dec 28; 14(1):231-6. PubMed ID: 23534729
    [Abstract] [Full Text] [Related]

  • 8. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Zhang Y, Ding D, Wang X, Zhu Z, Huang M, He X.
    Int J Colorectal Dis; 2011 Oct 28; 26(10):1257-64. PubMed ID: 21541661
    [Abstract] [Full Text] [Related]

  • 9. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Nov 28; 124(1):229-35. PubMed ID: 20204500
    [Abstract] [Full Text] [Related]

  • 10. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H, Niu YM, Wang RX, Li HZ, Chen N.
    Genet Mol Res; 2011 Nov 22; 10(4):3356-64. PubMed ID: 22179996
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
    Zhang RC, Mou SH.
    Tumour Biol; 2013 Apr 22; 34(2):901-7. PubMed ID: 23271362
    [Abstract] [Full Text] [Related]

  • 12. XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.
    Yuan L, Cui D, Zhao EJ, Jia CZ, Wang LD, Lu WQ.
    World J Gastroenterol; 2011 May 14; 17(18):2343-8. PubMed ID: 21633601
    [Abstract] [Full Text] [Related]

  • 13. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
    Lin H, Lin D, Zheng C.
    Diagn Pathol; 2014 Jan 20; 9():15. PubMed ID: 24443924
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.
    Wang Y, Zhao Y, Zhang A, Ma J, Wang Z, Zhang X.
    Int J Clin Exp Pathol; 2015 Jan 20; 8(10):12949-54. PubMed ID: 26722489
    [Abstract] [Full Text] [Related]

  • 15. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
    Zhu HL, Bao JM, Lin PX, Li WX, Zou ZN, Huang YE, Chen Q, Shen H.
    Asian Pac J Cancer Prev; 2014 Jan 20; 15(16):6619-25. PubMed ID: 25169498
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
    Ma Q, Qi C, Tie C, Guo Z.
    Gene; 2013 Nov 10; 530(2):309-14. PubMed ID: 23973729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.
    Wu KG, He XF, Li YH, Xie WB, Huang X.
    Tumour Biol; 2014 Nov 10; 35(11):11243-59. PubMed ID: 25113251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
    Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyrén O.
    Carcinogenesis; 2006 Sep 10; 27(9):1835-41. PubMed ID: 16571649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.